Biogen and Eisai’s dementia drug tie-up pays off with US approval 2021-06-08T05:36:45-04:00June 8th, 2021| share this article! New treatment holds promise for Alzheimer’s patients but obstacles remain Read More share this article! Related Posts Japan pushes LNG in Southeast Asia as its own demand slows May 2nd, 2024 ZA Bank eyes digital assets services ahead of new regulation next month May 2nd, 2024 HSBC sees growth in loans to ultra-rich backed by art, jets, other assets May 2nd, 2024 Chinese EV trio Li Auto, Xpeng and Nio post mixed April sales amid bruising price war May 1st, 2024
